These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18226062)

  • 1. Assessing developmental toxicant exposures via biomonitoring.
    Needham LL; Calafat AM; Barr DB
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):100-8. PubMed ID: 18226062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National exposure measurements for decisions to protect public health from environmental exposures.
    Pirkle JL; Osterloh J; Needham LL; Sampson EJ
    Int J Hyg Environ Health; 2005; 208(1-2):1-5. PubMed ID: 15881972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collection and use of exposure data from human milk biomonitoring in the United States.
    Fenton SE; Condon M; Ettinger AS; LaKind JS; Mason A; McDiarmid M; Qian Z; Selevan SG
    J Toxicol Environ Health A; 2005 Oct; 68(20):1691-712. PubMed ID: 16176916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.
    Hays SM; Aylward LL
    J Appl Toxicol; 2009 May; 29(4):275-88. PubMed ID: 19115313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring for environmental exposures to arsenic.
    Orloff K; Mistry K; Metcalf S
    J Toxicol Environ Health B Crit Rev; 2009 Aug; 12(7):509-24. PubMed ID: 20183531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustainability, synthetic chemicals, and human exposure.
    Podein RJ; Hernke MT; Fortney LW; Rakel DP
    Explore (NY); 2010; 6(3):186-8. PubMed ID: 20451154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental chemicals in people: challenges in interpreting biomonitoring information.
    LaKind JS; Barraj L; Tran N; Aylward LL
    J Environ Health; 2008 May; 70(9):61-4. PubMed ID: 18517157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing children's exposures: beyond NHANES.
    Needham LL; Barr DB; Calafat AM
    Neurotoxicology; 2005 Aug; 26(4):547-53. PubMed ID: 16112320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human biomonitoring activities--programmes by industry.
    Boogaard PJ
    Int J Hyg Environ Health; 2007 May; 210(3-4):259-61. PubMed ID: 17275410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human milk biomonitoring data: interpretation and risk assessment issues.
    LaKind JS; Brent RL; Dourson ML; Kacew S; Koren G; Sonawane B; Tarzian AJ; Uhl K
    J Toxicol Environ Health A; 2005 Oct; 68(20):1713-69. PubMed ID: 16176917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of xenobiotic chemicals in the maternal-fetal unit.
    Barr DB; Bishop A; Needham LL
    Reprod Toxicol; 2007; 23(3):260-6. PubMed ID: 17386996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The faroes statement: human health effects of developmental exposure to chemicals in our environment.
    Grandjean P; Bellinger D; Bergman A; Cordier S; Davey-Smith G; Eskenazi B; Gee D; Gray K; Hanson M; van den Hazel P; Heindel JJ; Heinzow B; Hertz-Picciotto I; Hu H; Huang TT; Jensen TK; Landrigan PJ; McMillen IC; Murata K; Ritz B; Schoeters G; Skakkebaek NE; Skerfving S; Weihe P
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):73-5. PubMed ID: 18226057
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal-infant biomonitoring of environmental chemicals: the epidemiologic challenges.
    Arbuckle TE
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):931-7. PubMed ID: 20706992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive matrices in human biomonitoring: a review.
    Esteban M; Castaño A
    Environ Int; 2009 Feb; 35(2):438-49. PubMed ID: 18951632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
    Liao KH; Tan YM; Clewell HJ
    Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring concentrations of persistent organic pollutants in the general population: the international experience.
    Porta M; Puigdomènech E; Ballester F; Selva J; Ribas-Fitó N; Llop S; López T
    Environ Int; 2008 May; 34(4):546-61. PubMed ID: 18054079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.